Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• WBR0942  + (Phosphodiesterase inhibition)
• WBR0377  + (Pityriasis rosea)
• WBR0847  + (Plasmin)
• WBR0087  + (Pleitropy)
• WBR0014  + (Pleuritis)
• WBR0713  + (Polycythemia vera)
• WBR0385  + (Polygenic)
• WBR1031  + (Polymyalgia rheumatica)
• WBR1101  + (Polymyositis)
• WBR0474  + (Polyostotic fibrous dysplasia)
• WBR0675  + (Polyuria)
• WBR0025  + (Poor R-wave progression)
• WBR0035  + (Poor R-wave progression)
• WBR245  + (Porphobilinogen (PBG))
• WBR0532  + (Positive Babinski sign and muscle fasciculations)
• WBR289  + (Positive pressure ventilation)
• WBR591  + (Post operative delirium)
• WBR0384  + (Post-infectious cough)
• WBR0823  + (Post-operatively in the recovery room)
• WBR0431  + (Post-procedural stent thrombosis)
• WBR0542  + (Post-streptococcal glomerulonephritis (PSGN))
• WBR0495  + (Posterior cord of the brachial plexus)
• WBR0769  + (Poststreptococcal glomerulonephritis (PSGN))
• WBR1075  + (Potassium)
• WBR0393  + (Pralidoxime)

• WBR0180  + (Prazosin)

• WBR0321  + (Precipitation of monosodium urate crystals in joints on arthrocentesis)
• WBR0009  + (Prednisolone.)
• WBR292  + (Preformed toxins in ingested food)
• WBR0886  + (Pregnenolone)
• WBR1137  + (Prescribe Buspirone)
• WBR0837  + (Prescribe Pantoprazole)
• WBR0045  + (Presence of cell membrane with increased osmotic fragility)
• WBR0090  + (Presence of eosinophils on a sputum sample)
• WBR0748  + (Presence of urinary IgG and IgM during clinical work-up)
• WBR0631  + (Presence of viral RNA molecules inhibiting protein degradation by the ubiquitin-proteasome pathway)
• WBR0039  + (Prevalence will decrease and incidence will remain unchanged)
• WBR249  + (Primaquine)
• WBR0074  + (Primaquine)
• WBR0999  + (Procainamide)
• WBR0961  + (Proceed with the invasive procedure)
• WBR0004  + (Proceed with treatment of the suspected disease.)
• WBR0613  + (Production of CSF)
• WBR0484  + (Production of antibodies)
• WBR0375  + (Prolonged PR interval)
• WBR0012  + (Prominent ‘x’ descent)
• WBR0273  + (Promotes neutropenia)
• WBR0481  + (Promotes the degradation of LDL receptors)
• WBR0398  + (Pseudo hypoparathyroidism)
• WBR0809  + (Pseudohyphae and budding spores in the esophageal squamous debris)
• WBR0206  + (Pseudopalisading pleomorphic cells)